Recurrent Ovarian Carcinoma
Showing NaN - NaN of 16
Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,
Not yet recruiting
- Fallopian Tube Carcinosarcoma
- +14 more
- Biopsy
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 28, 2023
Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma
Active, not recruiting
- Recurrent Endometrial Endometrioid Adenocarcinoma
- +4 more
-
Anchorage, Alaska
- +584 more
Jan 28, 2023
Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive
Recruiting
- Malignant Abdominal Neoplasm
- +26 more
- Cisplatin
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +14 more
- Cediranib
- +9 more
-
Birmingham, Alabama
- +399 more
Dec 30, 2022
Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United
Active, not recruiting
- Metastatic Fallopian Tube Carcinoma
- +11 more
- Berzosertib
- +4 more
-
Phoenix, Arizona
- +13 more
Dec 2, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States
Active, not recruiting
- Metastatic Malignant Solid Neoplasm
- +4 more
- Laboratory Biomarker Analysis
- +4 more
-
Phoenix, Arizona
- +14 more
Sep 1, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Not yet recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +6 more
- Biopsy
- Pegylated SN-38 Conjugate PLX038
-
Rochester, MinnesotaMayo Clinic
Jul 19, 2022
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +4 more
-
Phoenix, Arizona
- +2 more
Jun 27, 2022
Ovarian Serous Tumor, Recurrent Ovarian Carcinoma Trial in Rochester (Auranofin, Laboratory Biomarker Analysis, Sirolimus)
Active, not recruiting
- Ovarian Serous Tumor
- Recurrent Ovarian Carcinoma
- Auranofin
- +2 more
-
Rochester, MinnesotaMayo Clinic
Mar 22, 2022
Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,
Completed
- Ovarian Endometrioid Adenocarcinoma
- +8 more
- Everolimus
- +2 more
-
Jacksonville, Florida
- +1 more
Sep 28, 2020
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,
Completed
- Adult Hepatocellular Carcinoma
- +44 more
- Bevacizumab
- Temsirolimus
-
Scottsdale, Arizona
- +60 more
Jan 24, 2019